Acta Cardiologica Sinica最新文献

筛选
英文 中文
A Case with a Short QT Interval and Idiopathic Ventricular Fibrillation Due to Carnitine Transporter Defect. 肉碱转运体缺陷导致 QT 间期短和特发性室颤的病例
IF 1.8 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-11-01 DOI: 10.6515/ACS.202411_40(6).20240721A
Chen-Jung Hsu, Cheng-I Wu, Yenn-Jiang Lin
{"title":"A Case with a Short QT Interval and Idiopathic Ventricular Fibrillation Due to Carnitine Transporter Defect.","authors":"Chen-Jung Hsu, Cheng-I Wu, Yenn-Jiang Lin","doi":"10.6515/ACS.202411_40(6).20240721A","DOIUrl":"10.6515/ACS.202411_40(6).20240721A","url":null,"abstract":"","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 6","pages":"801-804"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579693/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142708978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biventricular Cardiomyopathy in a Setting of Neutropenic Sepsis, Clenbuterol and 2,4 Dinitrophenol Abuse - A Case Report. 中性粒细胞败血症、盐酸克伦特罗和 2,4 二硝基酚滥用导致的双心室心肌病 - 病例报告。
IF 1.8 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-11-01 DOI: 10.6515/ACS.202411_40(6).20240925A
Fan Yang, Wen Jun Eran Sim, Shiun Woei Wong
{"title":"Biventricular Cardiomyopathy in a Setting of Neutropenic Sepsis, Clenbuterol and 2,4 Dinitrophenol Abuse - A Case Report.","authors":"Fan Yang, Wen Jun Eran Sim, Shiun Woei Wong","doi":"10.6515/ACS.202411_40(6).20240925A","DOIUrl":"10.6515/ACS.202411_40(6).20240925A","url":null,"abstract":"","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 6","pages":"810-813"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579685/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142708984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short and Mid-Term Outcomes of Rotarex Mechanical Thrombectomy for Acute Limb Ischemia in Taiwan: A Retrospective Study in a Single Medical Center. 台湾 Rotarex 机械血栓切除术治疗急性肢体缺血的短期和中期疗效:单个医疗中心的回顾性研究。
IF 1.8 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-11-01 DOI: 10.6515/ACS.202411_40(6).20240812A
Shun-Kai Yu, Nai-Yu Chi, Ching-Tang Chang, Tzu-Chieh Lin, Yi-Hsueh Liu, Wei-Chung Tsai, Wen-Hsien Lee, Ho-Ming Su, Tsung-Hsien Lin, Po-Chao Hsu
{"title":"Short and Mid-Term Outcomes of Rotarex Mechanical Thrombectomy for Acute Limb Ischemia in Taiwan: A Retrospective Study in a Single Medical Center.","authors":"Shun-Kai Yu, Nai-Yu Chi, Ching-Tang Chang, Tzu-Chieh Lin, Yi-Hsueh Liu, Wei-Chung Tsai, Wen-Hsien Lee, Ho-Ming Su, Tsung-Hsien Lin, Po-Chao Hsu","doi":"10.6515/ACS.202411_40(6).20240812A","DOIUrl":"10.6515/ACS.202411_40(6).20240812A","url":null,"abstract":"<p><strong>Background: </strong>Acute limb ischemia (ALI) is a medical emergency necessitating immediate action to avert irreversible tissue harm and limb loss. Rotarex mechanical thrombectomy (RMT) has become an efficient treatment alternative for ALI. However, there is a lack of data on RMT in Taiwan.</p><p><strong>Methods: </strong>We retrospectively analyzed 61 ALI patients treated with RMT at our hospital between January 2016 and January 2022. We collected baseline characteristics, laboratory and angiographic data. We also examined the outcomes at 30 days, 6 months, and 1 year, including major amputations, minor amputations, all-cause mortality, and major adverse limb events (MALEs).</p><p><strong>Results: </strong>Among the 61 RMT-treated patients, the average age was 70 ± 14 years. ALI affected the upper extremities in 9 cases and lower extremities in 52 cases. One-year outcomes revealed 2 major amputations (3.3%), 2 minor amputations (3.3%), 6 all-cause deaths (9.8%), and 10 MALEs (16.4%). After multiple logistic regression analysis, hemoglobin drop was significantly associated with 1-year all-cause mortality, and a history of peripheral artery disease (PAD) was significantly associated with MALEs.</p><p><strong>Conclusions: </strong>Our research is the first investigation into the application of RMT for ALI in Taiwan. The short- and mid-term outcomes after RMT for ALI revealed reductions in amputation, mortality, and MALE rates. In addition, a decline in hemoglobin level was a significant predictor of increased mortality, and a history of PAD was a significant predictor of increased MALEs following RMT.</p>","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 6","pages":"793-800"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579683/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Distribution of Left Ventricular Ejection Fraction, Characteristics, and Clinical Outcomes of Patients with Newly Diagnosed Heart Failure in Taiwan. 台湾新诊断心力衰竭患者的左心室射血分数分布、特征和临床结果。
IF 1.8 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-11-01 DOI: 10.6515/ACS.202411_40(6).20240918A
Cze Ci Chan, Hung-Chi Su, Chi Chuang, Tzyy-Jer Hsu, Fu-Chih Hsiao, Pao-Hsien Chu
{"title":"The Distribution of Left Ventricular Ejection Fraction, Characteristics, and Clinical Outcomes of Patients with Newly Diagnosed Heart Failure in Taiwan.","authors":"Cze Ci Chan, Hung-Chi Su, Chi Chuang, Tzyy-Jer Hsu, Fu-Chih Hsiao, Pao-Hsien Chu","doi":"10.6515/ACS.202411_40(6).20240918A","DOIUrl":"10.6515/ACS.202411_40(6).20240918A","url":null,"abstract":"<p><strong>Background: </strong>Data regarding the distribution of left ventricular ejection fraction among patients with newly diagnosed heart failure (HF) and the outcomes of patients with heart failure with preserved ejection fraction (HFpEF) in Taiwan are limited.</p><p><strong>Methods: </strong>Patients with newly diagnosed HF were identified from a multi-institutional database between 2016 and 2020. Outcomes were compared between patients with HFpEF and heart failure with reduced ejection fraction (HFrEF) after propensity score matching (PSM).</p><p><strong>Results: </strong>Of 7,736 newly diagnosed HF patients, 4,393 (56.8%) had HFpEF and 1,977 (25.6%) had HFrEF. The HFpEF group was older (71.5 vs. 64.2 years) and more likely to be female (48.9% vs. 31.1%). Comorbidities were more common in the HFpEF patients. Median follow-up was 2.1 years. Prior to PSM, the HFpEF patients had higher all-cause mortality risk [hazard ratio (HR) 1.21, 95% confidence interval (CI) 1.11-1.33] but lower cardiovascular (CV) death risk (HR 0.84, 95% CI 0.72-0.97) compared to those with HFrEF. The HFpEF group had a trend of higher overall hospitalization risk (HR 1.06, 95% CI 0.99-1.14), but lower HF hospitalization risk (HR 0.61, 95% CI 0.55- 0.67). After PSM, all-cause mortality and overall hospitalization were comparable. The HFpEF group had lower rates of CV death (HR 0.82, 95% CI 0.68-1.0) and HF hospitalization (HR 0.60, 95% CI 0.53-0.69) compared to the HFrEF group.</p><p><strong>Conclusions: </strong>Among patients with newly diagnosed HF, HFpEF is the predominant phenotype, characterized by older age, higher female prevalence, and increased comorbidities. After adjusting for these factors, all-cause death and hospitalization risks became similar between the HFpEF and HFrEF patients. The HFpEF patients had lower risks of CV death and HF hospitalization.</p>","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 6","pages":"740-750"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579679/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142708954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Letter to the Editor: Clinical Implication of Atrial Conductance Impairment on New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Implantation. 回应致编辑的信:经导管主动脉瓣植入术后心房传导功能障碍对新发心房颤动的临床影响。
IF 1.8 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-11-01 DOI: 10.6515/ACS.202411_40(6).20240919A
Ugur Nadir Karakulak
{"title":"Response to Letter to the Editor: Clinical Implication of Atrial Conductance Impairment on New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Implantation.","authors":"Ugur Nadir Karakulak","doi":"10.6515/ACS.202411_40(6).20240919A","DOIUrl":"10.6515/ACS.202411_40(6).20240919A","url":null,"abstract":"","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 6","pages":"822-823"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579682/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Implication of Atrial Conductance Impairment on New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Implantation. 经导管主动脉瓣植入术后心房传导功能障碍对新发心房颤动的临床影响
IF 1.8 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-11-01 DOI: 10.6515/ACS.202411_40(6).20240915A
Naoya Kataoka, Teruhiko Imamura
{"title":"Clinical Implication of Atrial Conductance Impairment on New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Implantation.","authors":"Naoya Kataoka, Teruhiko Imamura","doi":"10.6515/ACS.202411_40(6).20240915A","DOIUrl":"10.6515/ACS.202411_40(6).20240915A","url":null,"abstract":"","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 6","pages":"819"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579681/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142708986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastropleural Fistula: A Rare But Formidable Complication of Type B Aortic Dissection. 胃胸膜瘘:B型主动脉夹层罕见但棘手的并发症
IF 1.8 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-11-01 DOI: 10.6515/ACS.202411_40(6).20240930A
Po-Ju Chen, Juey-Ming Shih
{"title":"Gastropleural Fistula: A Rare But Formidable Complication of Type B Aortic Dissection.","authors":"Po-Ju Chen, Juey-Ming Shih","doi":"10.6515/ACS.202411_40(6).20240930A","DOIUrl":"10.6515/ACS.202411_40(6).20240930A","url":null,"abstract":"","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 6","pages":"814-817"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579686/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142708996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of Length of Stay after Transcatheter Aortic Valve Implantation: Impact of Prognostic Nutritional Index. 经导管主动脉瓣植入术后住院时间的预测因素:预后营养指数的影响。
IF 1.8 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-09-01 DOI: 10.6515/ACS.202409_40(5).20240713A
Metin Coksevim, Mustafa Yenerçağ, Ahmet Onur Kocasarı, Abdülkadir Kara, Ömer Kertmen, Korhan Soylu
{"title":"Predictors of Length of Stay after Transcatheter Aortic Valve Implantation: Impact of Prognostic Nutritional Index.","authors":"Metin Coksevim, Mustafa Yenerçağ, Ahmet Onur Kocasarı, Abdülkadir Kara, Ömer Kertmen, Korhan Soylu","doi":"10.6515/ACS.202409_40(5).20240713A","DOIUrl":"10.6515/ACS.202409_40(5).20240713A","url":null,"abstract":"<p><strong>Background: </strong>Pre-transcatheter aortic valve replacement (TAVR) nutritional status can potentially affect the length of hospital stay (LoS) after TAVR. The Prognostic Nutritional Index (PNI) is a widely recognised nutritional index. We aimed to determine the effect of PNI on LoS in patients undergoing TAVR.</p><p><strong>Methods: </strong>The study population (158 patients) was divided into two groups: early discharge (LoS ≤ 3 days) and late discharge (LoS > 3 days). PNI was calculated before TAVR.</p><p><strong>Results: </strong>In the LoS > 3 days group, the median age, creatinine level, rate of surgical access site closure and rate of major complications were higher, whereas estimated glomerular filtration rate, albumin, haemoglobin, lymphocyte count and PNI were significantly lower. Receiver operating characteristic curve analysis revealed a PNI cutoff of 39 (area under the curve = 0.778, p < 0.001) with 86.8% sensitivity and 55.2% specificity for predicting extended LoS. The 30-day endpoint analysis revealed significantly higher rates of death and hospitalisation with LoS > 3 days and PNI ≤ 39. Multivariate binary logistic regression analysis identified several independent predictors of extended LoS: severe renal insufficiency [odds ratio: 3.951 (95% confidence interval: 1.281-12.191); p = 0.017], surgical access site closure [4.353 (1.701-11.141); p = 0.002), complications [7.448 (1.305-42.518); p = 0.024] and PNI < 39 [5.906 (2.375-14.684); p < 0.005].</p><p><strong>Conclusions: </strong>Decreased PNI may be associated with LoS > 3 days after TAVR. Nutritional status assessed using PNI may be a useful independent predictor of LoS after TAVR.</p>","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 5","pages":"608-617"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413947/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142278630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
18F-Florbetaben PET/CT for the Diagnosis and Subtyping of Cardiac Amyloidosis: A Case Series and Review of the Literature. 18F-Florbetaben PET/CT 用于心脏淀粉样变性的诊断和亚型划分:病例系列和文献综述。
IF 1.8 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-09-01 DOI: 10.6515/ACS.202409_40(5).20240617D
Yu-Cheng Shih, Bing-Hsiean Tzeng, Meng-Chieh Tsai, Yuan-Bin Yu, Yu-Chien Shiau, Shan-Ying Wang, Yen-Wen Wu
{"title":"<sup>18</sup>F-Florbetaben PET/CT for the Diagnosis and Subtyping of Cardiac Amyloidosis: A Case Series and Review of the Literature.","authors":"Yu-Cheng Shih, Bing-Hsiean Tzeng, Meng-Chieh Tsai, Yuan-Bin Yu, Yu-Chien Shiau, Shan-Ying Wang, Yen-Wen Wu","doi":"10.6515/ACS.202409_40(5).20240617D","DOIUrl":"10.6515/ACS.202409_40(5).20240617D","url":null,"abstract":"<p><strong>Objectives: </strong>Cardiac amyloidosis (CA) is a type of systemic amyloidosis. Amyloid-targeting positron emission tomography (PET) has shown potential as an imaging method for CA. However, the optimal imaging protocol and role of <sup>18</sup>F-florbetaben (FBB) PET in the diagnosis and subtyping of CA have yet to be determined.</p><p><strong>Methods: </strong>Patients with suspected CA who had positive or equivocal results of technetium-99m pyrophosphate (PYP) scintigraphy were enrolled for dynamic and late FBB PET imaging. In addition to visual assessment, a kinetic modeling-based approach including target-to-background ratio (TBR) and myocardial retention fraction (RF) of serial images reconstructed from a 20-min dynamic acquisition, and a late image at 110 min post-injection were performed. We compared FBB PET measures of four typical patients with light chain amyloidosis (AL), wild-type transthyretin amyloidosis (ATTRwt), variant transthyretin amyloidosis (ATTRv), and heart failure, respectively. We also reviewed the literature on the clinical use of amyloid PET in CA.</p><p><strong>Results: </strong>Myocardial tracer retention was only found in the AL patient on the late images. TBR and RF were highest in the AL patient followed by the ATTRwt patient, and lowest in the ATTRv and non-CA patients.</p><p><strong>Conclusions: </strong>FBB PET has potential in the detection and non-invasive subtyping of CA, especially in subjects with equivocal PYP findings or monoclonal gammopathy.</p>","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 5","pages":"635-643"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413950/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142278617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part I. 2024 台湾心脏病学会动脉粥样硬化性心血管疾病一级预防指南--第一部分。
IF 1.8 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-09-01 DOI: 10.6515/ACS.202409_40(5).20240724A
Ting-Hsing Chao, Tsung-Hsien Lin, Cheng-I Cheng, Yen-Wen Wu, Kwo-Chang Ueng, Yih-Jer Wu, Wei-Wen Lin, Hsing-Ban Leu, Hao-Min Cheng, Chin-Chou Huang, Chih-Cheng Wu, Chao-Feng Lin, Wei-Ting Chang, Wen-Han Pan, Pey-Rong Chen, Ke-Hsin Ting, Chun-Hung Su, Chih-Sheng Chu, Kuo-Liong Chien, Hsueh-Wei Yen, Yu-Chen Wang, Ta-Chen Su, Pang-Yen Liu, Hsien-Yuan Chang, Po-Wei Chen, Jyh-Ming Jimmy Juang, Ya-Wen Lu, Po-Lin Lin, Chao-Ping Wang, Yu-Shien Ko, Chern-En Chiang, Charles Jia-Yin Hou, Tzung-Dau Wang, Yen-Hung Lin, Po-Hsun Huang, Wen-Jone Chen
{"title":"2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part I.","authors":"Ting-Hsing Chao, Tsung-Hsien Lin, Cheng-I Cheng, Yen-Wen Wu, Kwo-Chang Ueng, Yih-Jer Wu, Wei-Wen Lin, Hsing-Ban Leu, Hao-Min Cheng, Chin-Chou Huang, Chih-Cheng Wu, Chao-Feng Lin, Wei-Ting Chang, Wen-Han Pan, Pey-Rong Chen, Ke-Hsin Ting, Chun-Hung Su, Chih-Sheng Chu, Kuo-Liong Chien, Hsueh-Wei Yen, Yu-Chen Wang, Ta-Chen Su, Pang-Yen Liu, Hsien-Yuan Chang, Po-Wei Chen, Jyh-Ming Jimmy Juang, Ya-Wen Lu, Po-Lin Lin, Chao-Ping Wang, Yu-Shien Ko, Chern-En Chiang, Charles Jia-Yin Hou, Tzung-Dau Wang, Yen-Hung Lin, Po-Hsun Huang, Wen-Jone Chen","doi":"10.6515/ACS.202409_40(5).20240724A","DOIUrl":"10.6515/ACS.202409_40(5).20240724A","url":null,"abstract":"<p><p>Atherosclerotic cardiovascular disease (ASCVD) is one of the leading causes of death worldwide and in Taiwan. It is highly prevalent and has a tremendous impact on global health. Therefore, the Taiwan Society of Cardiology developed these best-evidence preventive guidelines for decision-making in clinical practice involving aspects of primordial prevention including national policies, promotion of health education, primary prevention of clinical risk factors, and management and control of clinical risk factors. These guidelines cover the full spectrum of ASCVD, including chronic coronary syndrome, acute coronary syndrome, cerebrovascular disease, peripheral artery disease, and aortic aneurysm. In order to enhance medical education and health promotion not only for physicians but also for the general public, we propose a slogan <b>(2H2L)</b> for the primary prevention of ASCVD on the basis of the essential role of healthy dietary pattern and lifestyles: \"<b>Healthy Diet and Healthy Lifestyles to Help Your Life and Save Your Lives</b>\". We also propose an acronym of the modifiable risk factors/enhancers and relevant strategies to facilitate memory: \" <b>ABC<sub>2</sub>D<sub>2</sub>EFG-I'M<sub>2</sub> ACE\"</b>: Adiposity, Blood pressure, Cholesterol and Cigarette smoking, Diabetes mellitus and Dietary pattern, Exercise, Frailty, Gout/hyperuricemia, Inflammation/infection, Metabolic syndrome and Metabolic dysfunction-associated fatty liver disease, Atmosphere (environment), Chronic kidney disease, and Easy life (sleep well and no stress). Some imaging studies can be risk enhancers. Some risk factors/clinical conditions are deemed to be preventable, and healthy dietary pattern, physical activity, and body weight control remain the cornerstone of the preventive strategy.</p>","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 5","pages":"479-543"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413940/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142278618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信